trending Market Intelligence /marketintelligence/en/news-insights/trending/zewm-a-ctly1ysvelohrqg2 content esgSubNav
In This List

Sinovac Biotech extends termination date of going-private deal

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Sinovac Biotech extends termination date of going-private deal

Sinovac Biotech Ltd. extended the termination date of its going-private deal to April 26.

The original termination date was March 26.

The Beijing-based biopharmaceutical company agreed to go private in a $400 million transaction in June 2017. The transaction initially was expected to close in the second half of 2017.